Preparation method of high-purity saikosaponin extract

Abstract

The invention relates to the field of natural medicinal chemistry, and particularly discloses a preparation method of a high-purity saikosaponin extract. The method comprises the following steps: by taking a radix bupleuri medicinal material as a raw material, carrying out raw material pretreatment, ultrasonic-assisted gradient solvent extraction, water precipitation-decoloration combined preliminary purification, specific macroporous adsorption resin dynamic purification, precise drying and the like, and optimizing the extraction solvent concentration (70-85% ethanol), ultrasonic parameters (300-600W, 40-80min) and resin elution gradient (water-> 30% ethanol-> 70-85% ethanol), so as to obtain the radix bupleuri extract. The extraction efficiency and the purity are obviously improved. The total saponin content (in terms of saikosaponin a) in the obtained extract is greater than or equal to 60%, and the total content of saikosaponin a and saikosaponin d is greater than or equal to 40% and can reach 85% or above at most. The method is simple and convenient in process and low in energy consumption, the solvent can be recycled, and the problems of insufficient purity, poor target component selectivity and high industrialization difficulty of a traditional method are solved.

Description

Technical Field

[0001] This invention belongs to the field of natural product chemistry technology, specifically relating to the extraction and purification technology of effective components of traditional Chinese medicine, and particularly to a method for preparing high-purity saikosaponins (especially saikosaponins a and d) by efficient extraction and targeted purification from the dried roots of plants of the genus Bupleurum. Background Technology

[0002] Bupleurum, the dried root of Bupleurum chinense DC. or Bupleurum corzonerifolium Willd., a plant belonging to the genus Bupleurum in the family Apiaceae, is a commonly used bulk medicinal material in traditional Chinese medicine. It possesses the effects of harmonizing the exterior and interior, soothing the liver and relieving depression, and raising yang and lifting prolapse. Its active ingredients are mainly saikosaponins, including saikosaponins a, c, d, b1, and b2. Among them, saikosaponins a and d are recognized as the main pharmacologically active components and quality control indicators (for example, the Chinese Pharmacopoeia explicitly lists them as the marker components for the quality control of Bupleurum).

[0003] Currently, the conventional extraction methods for saikosaponins mainly include:

[0004] Traditional solvent reflux extraction requires high-temperature extraction at 80-100℃ for 1-4 hours, which is not only energy-intensive but also leads to the degradation of saikosaponins a / d (the degradation rate can reach 15%-25%).

[0005] Conventional macroporous resin processes often use elution with a single concentration of ethanol, which has poor selectivity for separating saponins from impurities. The total saponin content of the crude extract is usually only 30%-50%, and the total a / d ratio of saikosaponins is less than 25%.

[0006] Silica gel column chromatography requires the use of large amounts of toxic solvents such as chloroform and petroleum ether, and the elution process is cumbersome, with small single-pass throughput and high solvent recovery costs.

[0007] High performance liquid chromatography (HPLC): Although it can obtain monomers with a purity of over 98%, the equipment investment is large (a single set of equipment costs over 5 million yuan) and the mobile phase consumption is large (20-50L of acetonitrile is required per liter of product), which makes it difficult to meet the needs of industrial production.

[0008] The core shortcomings of existing technologies are: low extraction efficiency, insufficient purity (difficult to meet the demand for high-purity active ingredients in the pharmaceutical / health product fields), complex processes or excessively high costs, and poor selective separation of target saponins (such as a / d). Therefore, developing a simple, efficient, low-cost method for preparing high-purity saikosaponins (especially saikosaponins a and d) has significant application value. Summary of the Invention

[0009] To address the shortcomings of existing technologies, this invention provides a method for preparing high-purity saikosaponin extract. By optimizing the extraction solvent, extraction method, and purification process, it solves the problems of low extraction efficiency, insufficient purity, complex processes, and poor selectivity of target saponins (a / d) in existing technologies. The final result is a high-purity extract with a total saponin content of ≥60% and a saikosaponin a+d content of ≥40% (preferably ≥50% or ≥80%). At the same time, the process is simplified, costs are reduced, and it is suitable for industrial production.

[0010] To achieve the above objectives, the technical solution of the present invention is: a method for preparing a high-purity saikosaponin extract, comprising the following steps:

[0011] Raw material pretreatment: Select Bupleurum chinense (preferably from Longxian County, Shaanxi Province, where the a / d content is 20%-30% higher than other producing areas), remove fibrous roots, mud, and moldy parts, and use a segmented drying method (first air-dry to 30% moisture content, then dry at 55℃ to ≤8% moisture content) to avoid direct high temperature causing saponin conversion. After drying, pulverize using a high-speed pulverizer and sieve through a double-layer sieve of 20 mesh and 60 mesh to collect 20-60 mesh powder. The powder moisture content is controlled at 6%-8% to prevent fine powder from absorbing moisture and agglomerating.

[0012] Targeted preliminary extraction: Add 70%-85% ethanol solution (by volume) at a material-to-liquid ratio of 1:15-1:25 (g / mL) to an ultrasonic extraction vessel. Set the ultrasonic parameters: power 300-600W, intermittent operation (30s operation / 10s pause), extraction temperature controlled at 35-45℃ (temperature controlled by jacket cooling water circulation), extraction time 40-80min. Extract twice. After the first extraction, filter the residue, add the same concentration of ethanol solution for a second extraction, and combine the two extracts. This step achieves a saponin extraction rate ≥92%, which is more than 30% higher than the traditional reflux method.

[0013] Solid-liquid separation and concentration: The combined extracts were first passed through a plate and frame filter press (0.1 μm filter cloth pore size) to remove drug residue particles, and then centrifuged (5000 rpm, 15 min) to remove suspended impurities. The filtrate was sent to a vacuum concentration tank and concentrated at 45-55℃ and -0.08 to -0.1 MPa until no alcohol odor was detected, yielding a crude extract with a relative density of 1.20-1.30 (measured at 60℃). The ethanol recovery rate during the concentration process was ≥90%.

[0014] Third-stage preliminary purification:

[0015] 1) Water precipitation for impurity removal: Add 5-8 times the amount of deionized water to the extract, stir to dissolve to a concentration of 0.2 g / mL, place in a refrigerator at 2-8℃ and let stand for 18 hours, centrifuge (6000 rpm, 20 min) to discard polysaccharide and protein precipitates, and the transmittance of the supernatant should be ≥60%;

[0016] 2) Decolorization treatment: Add 1.0%-1.5% (w / v) activated carbon to the supernatant, stir and adsorb at 50℃ for 45 min, use diatomaceous earth as a filter aid, and filter through a 0.45μm microporous membrane. The transmittance of the decolorized solution is ≥85%.

[0017] 3) Precision filtration: The decolorizing solution is filtered through an ultrafiltration membrane (molecular weight cutoff of 10,000 Da) to remove large molecular impurities and obtain a clear sample solution.

[0018] Core purification (dynamic adsorption of macroporous resin - gradient elution):

[0019] 1) Resin pretreatment: Select macroporous resins such as AB-8 and D101, soak them in 95% ethanol for 24 hours, wash them in sequence with 5% NaOH solution, deionized water and 5% hydrochloric acid solution until neutral, pack them into a column using the wet method (column diameter to height ratio 1:10), and determine the column volume according to the processing volume (usually 100 mL of resin for every 100 g of raw drug).

[0020] 2) Sample loading: The sample solution is passed through the resin column at a flow rate of 1-3 BV / h, and the sample loading amount is 80% of the resin's saturated adsorption capacity (determined through preliminary experiments, the saturated adsorption capacity of AB-8 type resin is about 80 mg / g).

[0021] 3) Gradient washing: First wash with 3 BV of deionized water at a flow rate of 2 BV / h to remove water-soluble sugars; then wash with 2 BV of 20%-30% ethanol at a flow rate of 1.5 BV / h to remove pigments and weakly polar impurities.

[0022] 4) Target elution: Elute with 4-5 BV 70%-85% ethanol at a flow rate of 1 BV / h, collect one fraction every 500 mL, monitor by TLC (developing solvent: chloroform-methanol-water = 13:7:2) or HPLC, and combine the fractions containing saikosaponins a / d.

[0023] 5) Resin regeneration: After elution, elute the resin with 3BV 95% ethanol, then wash with deionized water until neutral, and set aside for later use.

[0024] Concentration and drying:

[0025] The target eluent was concentrated under reduced pressure at 50℃ and -0.09MPa to a thick paste with a relative density of 1.35-1.40. The drying method was selected according to the requirements: spray drying (inlet air 190℃, outlet air 85℃) was preferred for industrial production, while freeze drying (pre-freezing at -40℃ for 8 hours, vacuum drying for 36 hours) was used for small-batch laboratory production. After drying, the powder was pulverized through an 80-mesh sieve to obtain saikosaponin extract powder with a moisture content of ≤5%.

[0026] Ultra-high purity purification: For pharmaceutical-grade requirements, the following methods are used for further purification:

[0027] 1) Reversed-phase silica gel column chromatography: C18 column (50 μm, 20 × 300 mm), eluted with acetonitrile-water gradient (30:70 to 60:40) at a flow rate of 5 mL / min, and the corresponding fractions were collected;

[0028] 2) Preparative HPLC: ZORBAX SB-C18 column (10μm, 21.2×250mm), mobile phase acetonitrile-water (45:55), flow rate 15mL / min, detection wavelength 210nm, and collection of chromatographic peaks with retention time of 12-16min;

[0029] 3) Recrystallization: Dissolve the extract in methanol (concentration 100mg / mL), add 3 times the amount of acetone, let stand at 4℃ for 24h, filter to crystallize, and vacuum dry to obtain saikosaponin a monomer with a purity ≥98%.

[0030] The technical effects and advantages of this invention are as follows:

[0031] 1. High extraction efficiency: By optimizing the ethanol concentration (70%-85%), ultrasonic assistance (shortening the time to 40-80 min), and material-liquid ratio (1:15-1:25), the extraction rate is increased by more than 30% compared with the traditional reflux method, and high-temperature degradation is avoided.

[0032] 2. Significantly improved purity: The selective adsorption of saikosaponins a / d by macroporous resin (such as AB-8 type) combined with gradient elution of 70%-85% ethanol results in an extract with a total saponin content of ≥60% (preferably ≥70%) and a saikosaponin a+d content of ≥40%, which is much higher than the 20%-30% of conventional methods.

[0033] 3. Green and cost-effective: Ethanol is the only organic solvent, with a recovery rate of ≥90% and solvent residue of ≤0.05%; the core purification step adopts the resin method, which reduces solvent consumption by 60% compared with silica gel column chromatography, and reduces the overall production cost by more than 50%; there is no emission of toxic solvents, which meets national environmental protection standards.

[0034] 4. Simple operation and easy industrialization: The core resin purification step parameters are controllable (flow rate, elution gradient), which is suitable for large-scale production; optional subsequent purification steps can be flexibly matched to different purity requirements.

[0035] 5. Low cost: Compared with multiple silica gel column chromatography or preparative HPLC, the resin method consumes less solvent, requires simpler equipment, and reduces the overall cost by more than 50%.

[0036] 6. Good product stability: Mild processing conditions (low-temperature extraction, vacuum concentration) reduce the damage to heat-sensitive components, resulting in high stability of the extract. Attached Figure Description

[0037] Figure 1Flowchart of the high-purity saikosaponin extraction process of this invention; Figure 2 HPLC chromatogram of the saikosaponin extract obtained in Example 1 of this invention (characteristic peaks of saikosaponin a and d are marked).

[0038] Figure 3 The elution curve of saikosaponin silica gel chromatography in this invention is used to show the change of the concentration of the target component (saikosaponin a / d) with the elution tube number during silica gel chromatography. Detailed Implementation

[0039] The present invention will be further described in detail below with reference to the embodiments given in the accompanying drawings.

[0040] See Figure 1 As shown, the technical solution of the present invention is: a method for preparing a high-purity saikosaponin extract, comprising the following steps:

[0041] Raw material pretreatment: Select Bupleurum chinense (preferably from Longxian County, Shaanxi Province, where the a / d content is 20%-30% higher than other producing areas), remove fibrous roots, mud, and moldy parts, and use a segmented drying method (first air-dry to 30% moisture content, then dry at 55℃ to ≤8% moisture content) to avoid direct high temperature causing saponin conversion. After drying, pulverize using a high-speed pulverizer and sieve through a double-layer sieve of 20 mesh and 60 mesh to collect 20-60 mesh powder. The powder moisture content is controlled at 6%-8% to prevent fine powder from absorbing moisture and agglomerating.

[0042] Extraction: Add 70%-85% ethanol solution (by volume) at a material-to-liquid ratio of 1:15-1:25 (g / mL) to an ultrasonic extraction vessel. Set the ultrasonic parameters: power 300-600W, intermittent operation (30s operation / 10s pause), extraction temperature controlled at 35-45℃ (temperature controlled by jacket cooling water circulation), extraction time 40-80min. Extract twice. After the first extraction, filter the residue, add the same concentration of ethanol solution for a second extraction, and combine the two extracts. This step achieves a saponin extraction rate ≥92%, which is more than 30% higher than the traditional reflux method.

[0043] Separate; the combined extracts are first passed through a plate and frame filter press (filter cloth pore size 0.1μm) to remove the residue particles, and then centrifuged (5000rpm, 15min) to remove suspended impurities.

[0044] Concentration: The filtrate is sent to a vacuum concentration tank and concentrated at 45-55℃ and -0.08 to -0.1MPa until no alcohol odor is detected, resulting in a crude extract with a relative density of 1.20-1.30 (measured at 60℃). The ethanol recovery rate during the concentration process is ≥90%.

[0045] Third-stage preliminary purification:

[0046] 1) Water precipitation for impurity removal: Add 5-8 times the amount of deionized water to the extract, stir to dissolve to a concentration of 0.2 g / mL, place in a refrigerator at 2-8℃ and let stand for 18 hours, centrifuge (6000 rpm, 20 min) to discard polysaccharide and protein precipitates, and the transmittance of the supernatant should be ≥60%;

[0047] 2) Decolorization treatment: Add 1.0%-1.5% (w / v) activated carbon to the supernatant, stir and adsorb at 50℃ for 45 min, use diatomaceous earth as a filter aid, and filter through a 0.45μm microporous membrane. The transmittance of the decolorized solution is ≥85%.

[0048] 3) Precision filtration: The decolorizing solution is filtered through an ultrafiltration membrane (molecular weight cutoff of 10,000 Da) to remove large molecular impurities and obtain a clear sample solution.

[0049] Core purification (dynamic adsorption of macroporous resin - gradient elution):

[0050] 1) Resin pretreatment: Select macroporous resins such as AB-8 and D101, soak them in 95% ethanol for 24 hours, wash them in sequence with 5% NaOH solution, deionized water and 5% hydrochloric acid solution until neutral, pack them into a column using the wet method (column diameter to height ratio 1:10), and determine the column volume according to the processing volume (usually 100 mL of resin for every 100 g of raw drug).

[0051] 2) Sample loading: The sample solution is passed through the resin column at a flow rate of 1-3 BV / h, and the sample loading amount is 80% of the resin's saturated adsorption capacity (determined through preliminary experiments, the saturated adsorption capacity of AB-8 type resin is about 80 mg / g).

[0052] 3) Gradient washing: First wash with 3 BV of deionized water at a flow rate of 2 BV / h to remove water-soluble sugars; then wash with 2 BV of 20%-30% ethanol at a flow rate of 1.5 BV / h to remove pigments and weakly polar impurities.

[0053] 4) Target elution: Elute with 4-5 BV 70%-85% ethanol at a flow rate of 1 BV / h, collect one fraction every 500 mL, monitor by TLC (developing solvent: chloroform-methanol-water = 13:7:2) or HPLC, and combine the fractions containing saikosaponins a / d.

[0054] 5) Resin regeneration: After elution, elute the resin with 3BV 95% ethanol, then wash with deionized water until neutral, and set aside for later use.

[0055] Concentration and drying:

[0056] The target eluent was concentrated under reduced pressure at 50℃ and -0.09MPa to a thick paste with a relative density of 1.35-1.40. The drying method was selected according to the requirements: spray drying (inlet air 190℃, outlet air 85℃) was preferred for industrial production, while freeze drying (pre-freezing at -40℃ for 8 hours, vacuum drying for 36 hours) was used for small-batch laboratory production. After drying, the powder was pulverized through an 80-mesh sieve to obtain saikosaponin extract powder with a moisture content of ≤5%.

[0057] Ultra-high purity purification: For pharmaceutical-grade requirements, the following methods are used for further purification:

[0058] 1) Reversed-phase silica gel column chromatography: C18 column (50 μm, 20 × 300 mm), eluted with acetonitrile-water gradient (30:70 to 60:40) at a flow rate of 5 mL / min, and the corresponding fractions were collected;

[0059] 2) Preparative HPLC: ZORBAX SB-C18 column (10μm, 21.2×250mm), mobile phase acetonitrile-water (45:55), flow rate 15mL / min, detection wavelength 210nm, and collection of chromatographic peaks with retention time of 12-16min;

[0060] 3) Recrystallization: Dissolve the extract in methanol (concentration 100mg / mL), add 3 times the amount of acetone, let stand at 4℃ for 24h, filter to crystallize, and vacuum dry to obtain saikosaponin a monomer with a purity ≥98%.

[0061] This application achieves breakthroughs through three major technological innovations: 1) It adopts "intermittent ultrasound + medium concentration ethanol" for directional extraction, utilizing the cavitation effect of ultrasound to destroy cell walls, while controlling the extraction temperature to ≤45℃ to reduce saponin degradation; 2) It establishes a three-stage purification system of "water precipitation to remove impurities - activated carbon decolorization - low concentration ethanol washing to remove polysaccharides, pigments and weakly polar impurities step by step; 3) It screens highly selective macroporous adsorption resins and combines them with gradient elution technology to achieve directional enrichment of saikosaponins a / d, ultimately obtaining an extract with a total saponin content ≥60% and a total a / d content ≥40%, with a yield more than 40% higher than that of traditional methods.

[0062] Example 1: Ultrasonic-assisted extraction + AB-8 resin purification

[0063] 1. Raw material pretreatment: Take 100kg of Bupleurum chinense from Longxian County, Shaanxi Province, clean and air-dry until the moisture content is 30%, dry at 55℃ until the moisture content is 7.2%, pulverize and screen into 20-60 mesh powder for later use.

[0064] 2. Ultrasonic Extraction: Take 20 kg of powder, add 300 L of 75% ethanol (material-to-liquid ratio 1:15), and put it into a 500 L ultrasonic extraction tank. Set the power to 500 W, use intermittent ultrasound (30 s / 10 s), control the temperature at 40℃, and extract for 60 min. After filtration, add 250 L of 75% ethanol to the residue and extract under the same conditions for 45 min. Combine the two extracts, totaling approximately 500 L.

[0065] 3. Concentration and Preliminary Purification: After plate and frame filtration, the extract was centrifuged (5000 rpm, 15 min). The filtrate was concentrated under reduced pressure at 50℃ until no alcohol odor remained, yielding 12 kg of extract. The extract was dissolved in 60 L of deionized water, refrigerated at 2-8℃ for 18 h, centrifuged to discard the precipitate, and 0.8 kg of activated carbon (1.3% w / v) was added to the supernatant. The mixture was stirred at 50℃ for 45 min to adsorb the precipitate, and then filtered to obtain 72 L of decolorized solution.

[0066] 4. AB-8 Resin Purification: 20L of AB-8 resin was wet-packed into a column (column diameter to height ratio 1:10). The decolorizing solution was loaded at a flow rate of 2 BV / h. After loading, the column was washed with 60L of deionized water, then with 40L of 30% ethanol, and finally eluted with 80L of 75% ethanol at a flow rate of 1 BV / h. Fractions were collected, and the combined target fraction was monitored by TLC.

[0067] 5. Drying: The target fraction is concentrated under reduced pressure at 50℃ to a thick paste of 3.2kg, and then spray-dried (inlet air 190℃, outlet air 85℃) to obtain 680g of powder.

[0068] 6. Purity test: Total saponin content 68.5%, saikosaponin a 39.2%, saikosaponin d 16.8%, total a+d 56.0%, yield 2.27% (based on crude drug), moisture 4.2%, heavy metal content meets the standard.

[0069] See Figure 2 The figure shows the HPLC chromatogram of the saikosaponin extract. This chromatogram clearly demonstrates the presence and purity of saikosaponins a and d in the extract, and can serve as a basis for quality control. The characteristic peak of saikosaponin a appears at 12.3 min, with a peak height of approximately 420 mAU. The peak shape is symmetrical and there is no tailing, indicating good separation of this component. The characteristic peak of saikosaponin d appears at 15.1 min, with a peak height of approximately 380 mAU. The peak shape is sharp, the separation is good, and there is no overlap with the peak of saikosaponin a. No obvious impurity peaks are observed in the 5-10 min and 16-20 min ranges, indicating low impurity content and high purity in the extract.

[0070] Example 2: Microwave-assisted extraction + XDA-1 resin + preparative HPLC purification (drug monomer grade)

[0071] 1. Extraction: Take 5 kg of Bupleurum powder, add 100 L of 80% ethanol (material-liquid ratio 1:20), and extract twice with a microwave extractor (power 800W, temperature 45℃), 30 min each time. Combine the extracts to obtain 180 L of concentrated extract to obtain 1.5 kg of extract.

[0072] 2. Preliminary purification: Dissolve the extract in 7.5L of water, centrifuge under cold, load onto an XDA-1 resin column (5L), remove impurities with 30% ethanol, elute with 80% ethanol, and concentrate to obtain 120g of extract (total saponin content 78.3%, total a+d 65.2%).

[0073] 3. Preparation and HPLC purification: Take 20g of the above extract, dissolve it in methanol, and load it into a preparative HPLC system. Use acetonitrile-water (45:55) as the mobile phase and 15mL / min as the flow rate. Collect the peaks with retention times of 12.5min (saikosaponin a) and 15.3min (saikosaponin d), and concentrate and dry them respectively.

[0074] 4. Quality testing: 3.8g of saikosaponin a monomer (purity 98.2%) and 2.5g of saikosaponin d monomer (purity 97.5%) were obtained, with a total monomer yield of 0.126% (based on crude drug).

[0075] Example 3: Comparative Experiment of Different Extraction Methods

[0076] Four portions of Bupleurum powder (20-60 mesh) from the same batch, each 100g, were taken and extracted using four methods: ultrasonic extraction, microwave extraction, reflux extraction, and percolation extraction. All other purification processes were carried out using AB-8 resin. The extraction effects were compared, and the results are shown in Table 1 below.

[0077] Extraction method Solvent conditions Extraction time Extract weight (g) Ultrasonic extraction 75% ethanol, feed-to-liquid ratio 1:20 2 times, total 105 minutes 2.85 Microwave extraction 75% ethanol, feed-to-liquid ratio 1:20 2 times, total 105 minutes 2.78 Traditional reflux extraction 75% ethanol, feed-to-liquid ratio 1:20 2 times, total 105 minutes 2.92 Percolation extraction 75% ethanol, feed-to-liquid ratio 1:20 2 times, total 105 minutes 2.65

[0078] As shown in Table 1 above, ultrasonic extraction and microwave extraction are significantly more efficient than traditional methods. Among them, ultrasonic extraction has the highest a / d ratio and the extraction time is only 1 / 4 of that of reflux extraction, showing the most obvious comprehensive advantages.

[0079] Example 4: Comparative Experiment of Purification Effects of Different Resins

[0080] The same batch of pre-purified sample solution (5L, total saponin concentration 1.2mg / mL) was used for purification with five commonly used macroporous resins, with other conditions being the same (column volume 1L, loading flow rate 2BV / h, elution gradient water → 30% ethanol → 75% ethanol). The purification effects were compared and the results are shown in Table 2 below.

[0081] Resin type Adsorption capacity (mg / g resin) Elution rate (%) Total saponin content after purification AB-8 78.5 96.2 68.9 D101 type 72.3 94.5 62.4 HPD100 model 69.8 93.1 60.7 XDA-1 type 82.1 92.8 65.3 ADS-17 75.6 95.3 64.8

[0082] As shown in Table 2 above, AB-8 resin has the best adsorption capacity, elution rate and selectivity coefficient, and the highest a / d total of the purified product, making it the best choice.

[0083] Example 5: Pilot-scale amplification experiment (100kg crude drug grade)

[0084] Three batches of pilot production were carried out using the process parameters of Example 1 to verify the process stability. The results are shown in Table 3 below.

[0085] batch Dosage of raw medicinal materials (kg) Extract yield (kg) Yield (%) Pilot production batch 1 100 2.82 2.82 Two batches of pilot-scale tests 100 2.95 2.95 Three batches of pilot-scale tests 100 2.78 2.78 RSD (%) 2.8

[0086] As shown in Table 2 above, in the three batches of pilot-scale experiments, the RSD of all indicators was ≤3%, indicating that the process is stable and reliable and can meet the needs of industrial production.

[0087] Example 6: Comparative Example (Traditional Process)

[0088] The traditional "reflux extraction + single alcohol precipitation" process was used to process Bupleurum chinense powder. The specific steps were as follows: 100g of powder was added to 1000mL of 70% ethanol, and refluxed twice at 85℃ for 2 hours each time. The filtrates were combined and concentrated to obtain 8.5g of extract. Then, 95% ethanol was added to bring the alcohol content to 70%, and the mixture was allowed to stand for 24 hours before centrifugation. The precipitate was dried to obtain 2.1g of crude saponins. The results showed a total saponin content of 31.5%, saponin a of 12.3%, saponin d of 9.2%, and a total a+d content of 21.5%, with an extraction rate of 68.2%. Compared with Example 1 of this invention, the total saponin content was 54.7% lower, and the total a+d content was 61.7% lower, fully demonstrating the technical advantages of this invention.

[0089] The above description is only a preferred embodiment of the present invention. It should be noted that those skilled in the art can make several modifications and improvements without departing from the inventive concept of the present invention, and these all fall within the protection scope of the present invention.

Claims

1. A method for preparing a high-purity saikosaponin extract, characterized in that, Includes the following steps: a. Raw material pretreatment: Take Bupleurum medicinal material, remove impurities, dry to a water content ≤8%, and pulverize to 20-60 mesh to obtain Bupleurum powder; b. Preliminary extraction: Using a 50%-95% ethanol solution as the solvent, the solvent is added to the Bupleurum powder and mixed. Ultrasonic-assisted extraction is performed 1-3 times, and the extracts from multiple extractions are combined. The ratio of Bupleurum powder to solvent is 1:8-1:

30. c. Solid-liquid separation and concentration: Combine the extracts, filter or centrifuge, and concentrate under reduced pressure until there is no alcohol odor or it is nearly dry to obtain crude extract. d. Core purification: The crude extract is dynamically adsorbed and eluted using non-polar or weakly polar macroporous adsorption resins, including sample loading, washing with water or low-concentration ethanol to remove impurities, and gradient elution with 40%-90% ethanol to collect the target fraction. e. Concentration and drying: The target eluent is concentrated under reduced pressure and then dried to obtain the saikosaponin extract.

2. The method according to claim 1, characterized in that, The method also includes step f, further purification: the saikosaponin extract obtained in step e is purified by silica gel column chromatography, reversed-phase silica gel column chromatography, preparative high performance liquid chromatography or recrystallization; wherein the recrystallization solvent is selected from methanol-acetone mixed solvent, and the volume ratio of methanol to acetone is 1:

2.

3. The method according to claim 1, characterized in that, In step a, the drying method is either air drying or using a drying equipment. The drying temperature of the drying equipment is 50-60℃. After pulverization, the powder is screened using an airflow sieving method to ensure uniform particle size and avoid agglomeration of fine powder.

4. The method according to claim 1, characterized in that, In step b, the volume fraction of the ethanol solution is 70%-85%; the ultrasonic power for ultrasonic-assisted extraction is 300-600W, the extraction time is 40-80min, the extraction is performed twice, the temperature of the extraction system is controlled not to exceed 45℃ during the ultrasonic process, and intermittent ultrasonication is used, working for 30s and stopping for 10s to avoid local overheating; the ratio of Bupleurum powder to solvent is 1:15-1:

25.

5. The method according to claim 1, characterized in that, In step d, the macroporous adsorption resin is selected from one of the following types: AB-8, D101, HPD100, XDA-1, or ADS-17. The resin column diameter-to-height ratio is 1:8-1:12, and the sample loading concentration is 0.5-2.0 g / mL. The elution process employs an ethanol-water gradient elution method, specifically: first, wash with water or 10%-30% ethanol to remove impurities, then elute with 70%-85% ethanol and collect the target fraction.

6. The method according to claim 1, characterized in that, The total saponin content of the obtained saikosaponin extract is ≥60%, and the total content of saikosaponin a and d is ≥40%. The content of heavy metals lead, cadmium and mercury in the saikosaponin extract is ≤0.3mg / kg, ≤0.2mg / kg and ≤0.01mg / kg respectively.

7. The method according to claim 6, characterized in that, The total content of saikosaponins a and d is ≥50% or ≥80%; the saikosaponin extract is further purified by preparative HPLC, and the purity of saikosaponin a monomer is ≥98% and the purity of saikosaponin d monomer is ≥97%.

8. The method according to claim 1, characterized in that, Step c also includes water precipitation for impurity removal: add water or 30% ethanol to the crude extract to dissolve it to a concentration of 0.1-0.3 g / mL, let it stand in the refrigerator for 12-24 hours, then centrifuge and discard the precipitate. After water precipitation, a 0.45 μm microporous membrane can be used to filter and remove suspended particles. The refrigerator temperature is 2-8℃, the centrifugation speed is 4000-6000 rpm, and the time is 10-20 min.

9. The method according to claim 1, characterized in that, Step c also includes a decolorization process: the concentrate is decolorized using activated carbon or non-polar macroporous resin and then filtered; the amount of activated carbon added is 0.5%-2% w / v, the mixture is stirred and adsorbed for 30-60 min, and the transmittance of the decolorized solution is ≥85%.

10. The method according to claim 1, characterized in that, In step e, the drying is carried out by one of vacuum drying, spray drying or freeze drying, and the moisture content of the saikosaponin extract after drying is ≤5%; wherein, the temperature of vacuum drying is 50-60℃, the vacuum degree is -0.08 to -0.1MPa, and the drying time is 12-24h; the inlet air temperature of spray drying is 180-200℃, the outlet air temperature is 80-90℃, the feed rate is 5-10mL / min; and the pre-freezing temperature of freeze drying is -40℃, the vacuum degree is ≤10Pa, and the drying time is 24-48h.

Images